ATHXQAthersys, Inc.

About Athersys, Inc. (ATHXQ)

Athersys, Inc. (ATHXQ) is a Biotechnology company headquartered in Cleveland, OH, United States whose shares trade over-the-counter on the Expert Market tier.

Athersys, Inc. is a biotechnology company that is focused primarily in the field of regenerative medicine.

Products and services

Regenerative medicine company developing MultiStem® (invimestrocel) cell therapy for critical care indications

ATHXQ key facts

Ticker symbol

ATHXQ

Market tier

Expert Market

Sector

Healthcare

Industry

Biotechnology

Headquarters

Cleveland, OH, United States

Country of incorporation

US

Year of incorporation

2005

Employees

24

Estimated market cap

$61.7K (as of Apr 15, 2025)

Shares outstanding

61,748,035

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Latest filing

8K Report (Apr 1, 2024)

Athersys, Inc. leadership

• Daniel Camardo — CEO
• Maia Hansen — COO
• Kasey Rosado — CFO
• Alan Donovan — Accountant

Explore more: Biotechnology stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with A